Filtros de búsqueda

Lista de obras de Maryam Fouladi

A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report

artículo científico publicado en 2014

A comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials

artículo científico publicado en 2016

A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study

artículo científico publicado en 2013

A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas

artículo científico publicado en 2017

A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study

artículo científico publicado en 2013

A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study

artículo científico publicado en 2014

A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors

artículo científico publicado en 2015

A phase I trial of MK-2206 in children with refractory malignancies: a Children's Oncology Group study

artículo científico publicado en 2014

A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112).

artículo científico publicado en 2013

A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.

artículo científico publicado en 2017

A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium report

artículo científico publicado en 2014

A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study

artículo científico publicado en 2007

A pilot randomized trial of an online parenting skills program for pediatric traumatic brain injury: improvements in parenting and child behavior

artículo científico publicado en 2014

A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas

artículo científico publicado en 2015

A prognostic gene expression signature in infratentorial ependymoma

artículo científico publicado en 2012

AT-21INTEGRATED (EPI)GENOMIC ANALYSES IDENTIFY SUB-GROUP SPECIFIC THERAPEUTIC TARGETS IN CNS RHABDOID TUMORS.

artículo científico publicado en 2016

Altered irinotecan pharmacokinetics in pediatric high-grade glioma patients receiving enzyme-inducing anticonvulsant therapy

artículo científico publicado en 2002

Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma

artículo científico publicado en 2008

An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN)

artículo científico publicado en 2015

Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy

artículo científico publicado en 2005

BMI-1 is a potential therapeutic target in diffuse intrinsic pontine glioma

artículo científico publicado en 2017

BT-02FUNCTIONALLY-DEFINED THERAPEUTIC TARGETS IN DIFFUSE INTRINSIC PONTINE GLIOMA.

artículo científico publicado en 2015

Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).

artículo científico publicado en 2013

Carboplatin-based primary chemotherapy for infants and young children with CNS tumors

artículo científico publicado en 2009

Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas

artículo científico publicado en 2017

Chromosome 17 abnormalities in pediatric neuroblastic tumor with abundant neuropil and true rosettes

artículo científico publicado en 2006

Clear cell ependymoma: A clinicopathologic and radiographic analysis of 10 patients ⬇️

artículo científico publicado el 15 de noviembre de 2003

Clinical pharmacokinetics of amifostine and WR1065 in pediatric patients with medulloblastoma

artículo científico publicado en 2010

Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries.

artículo científico publicado en 2018

Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study

artículo científico publicado en 2017

Cytogenetic prognostication within medulloblastoma subgroups

artículo científico publicado en 2014

Determination of lapatinib (GW572016) in human plasma by liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS).

artículo científico publicado en 2005

Determination of the gamma-secretase inhibitor MK-0752 in human plasma by online extraction and electrospray tandem mass spectrometry (HTLC-ESI-MS/MS).

artículo científico publicado en 2010

Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease

artículo científico publicado en 2017

EPT-06OUTCOMES FOR PATIENTS WITH RECURRENT MEDULLOBLASTOMA OR EPENDYMOMA ENROLLED ON PHASE II CLINICAL TRIALS: AN ANALYSIS OF CONTEMPORARY CHILDREN'S ONCOLOGY GROUP (COG) AND PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) TRIALS.

artículo científico publicado en 2016

EPT-15A PHASE1/2 CLINICAL TRIAL OF VELIPARIB (ABT-888) AND RADIATION FOLLOWED BY MAINTENANCE THERAPY WITH VELIPARIB AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG): A PEDIATRIC BRAIN TUMOR CONSORTIUM I

artículo científico publicado en 2016

EPT-19PHASE I TRIAL OF PALBOCICLIB, A CDK4/6 INHIBITOR IN CHILDREN WITH RETINOBLASTOMA PROTEIN (RB1) + RECURRENT CENTRAL NERVOUS SYSTEM (CNS) TUMORS (PBTC 042).

artículo científico publicado en 2016

Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study

artículo científico publicado en 2013

End-of-life care preferences of pediatric patients with cancer.

artículo científico publicado en 2005

Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial.

artículo científico publicado en 2008

Ependymoma: new therapeutic approaches including radiation and chemotherapy

artículo científico publicado en 2005

Erratum: Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics

artículo científico publicado en 2016

Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo

artículo científico publicado en 2006

External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry

artículo científico publicado en 2017

Functionally defined therapeutic targets in diffuse intrinsic pontine glioma

artículo científico publicado en 2015

Functionally defined therapeutic targets in diffuse intrinsic pontine glioma.

artículo científico publicado en 2015

HG-109CONTEMPORARY SURVIVAL ENDPOINTS: AN INTERNATIONAL DIFFUSE INTRINSIC PONTINE GLIOMA REGISTRY STUDY.

artículo científico publicado en 2016

HG-41OUTCOMES FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA ENROLLED ON PHASE II CLINICAL TRIALS: AN ANALYSIS OF CONTEMPORARY CHILDREN'S ONCOLOGY GROUP (COG) AND PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) TRIALS.

artículo científico publicado en 2016

HG-75CLINICAL, RADIOLOGICAL, AND HISTO-GENETIC CHARACTERISTICS OF LONG-TERM SURVIVORS OF DIFFUSE INTRINSIC PONTINE GLIOMA: A COLLABORATIVE REPORT FROM THE INTERNATIONAL AND SIOP-E DIPG REGISTRIES.

artículo científico publicado en 2016

Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system

artículo científico publicado en 2013

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma

artículo científico publicado en 2012

IMMU-11. AN ANALYSIS OF IMMUNOPHENOTYPE, INCLUDING PD-L1 AND PD1 EXPRESSION, IN PEDIATRIC CNS MALIGNANCIES: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY.

artículo científico publicado en 2017

Inhibition of MEK confers hypersensitivity to X-radiation in the context of BRAF mutation in a model of childhood astrocytoma

artículo científico publicado en 2015

Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors

artículo científico publicado en 2016

Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma

artículo científico publicado en 2017

Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies

artículo científico publicado en 2005

Intertumoral Heterogeneity within Medulloblastoma Subgroups

artículo científico

Intratumoral hemorrhage among children with newly diagnosed, diffuse brainstem glioma

artículo científico publicado en 2006

LGG-08. A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY.

artículo científico publicado en 2017

MB-32FEASIBILITY OF VORINOSTAT COMBINED WITH ISOTRETINOIN AND CHEMOTHERAPY FOR YOUNG CHILDREN WITH NEWLY DIAGNOSED EMBRYONAL BRAIN TUMORS: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY.

artículo científico publicado en 2015

MB-94IMMUNOLOGIC PROFILE OF PATIENTS WITH NEWLY-DIAGNOSED MEDULLOBLASTOMA AT INITIAL DIAGNOSIS AND DURING STANDARD RADIATION AND CHEMOTHERAPY (PBTC-N11).

artículo científico publicado en 2016

MEK and RAF inhibitors: time for a paradigm shift in the treatment of pediatric low-grade gliomas?

artículo científico publicado en 2017

Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry

Medulloblastoma with melanotic differentiation: case report and review of the literature ⬇️

artículo científico publicado el 16 de octubre de 2010

Medullomyoblastoma: a radiographic and clinicopathologic analysis of six cases and review of the literature

artículo científico publicado en 2004

Molecular biology of pediatric brain tumors and impact on novel therapies

artículo científico publicado en 2015

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

artículo científico publicado en 2016

Nocardia farcinica Meningitis Masquerading as Central Nervous System Metastasis in a Child With Cerebellar Pilocytic Astrocytoma

artículo científico

Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma

scientific article published on May 2016

Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.

artículo científico publicado en 2003

Pediatric Low-Grade Gliomas: Next Biologically Driven Steps

artículo científico publicado en 2017

Pediatric low-grade gliomas: implications of the biologic era.

artículo científico publicado en 2016

Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report

artículo científico publicado en 2010

Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies

artículo científico publicado en 2013

Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumors

artículo científico publicado en 2009

Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study

artículo científico publicado en 2014

Phase I study of everolimus in pediatric patients with refractory solid tumors

artículo científico publicado en 2007

Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study

artículo científico publicado en 2011

Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study

artículo científico publicado en 2010

Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study

artículo científico publicado en 2016

Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma

artículo científico publicado en 2008

Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study

artículo científico publicado en 2015

Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology Group

artículo científico publicado en 2014

Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study

artículo científico publicado en 2006

Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas

artículo científico publicado en 2011

Population pharmacokinetic analysis of oxaliplatin in adults and children identifies important covariates for dosing

artículo científico publicado en 2015

Population pharmacokinetics of temozolomide and metabolites in infants and children with primary central nervous system tumors

artículo científico publicado en 2003

Population pharmacokinetics of temsirolimus and sirolimus in children with recurrent solid tumours: a report from the Children's Oncology Group

artículo científico publicado en 2016

Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas

artículo científico publicado en 2014

Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature

artículo científico publicado en 2016

Random-effects meta-analysis for systematic reviews of phase I clinical trials: Rare events and missing data

artículo científico publicado en 2016

Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis

artículo científico publicado en 2013

Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11).

artículo científico publicado en 2017

Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenografts.

artículo científico publicado en 2002

Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor

artículo científico publicado en 2004

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

artículo científico publicado en 2006

Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).

artículo científico publicado en 2005

Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics

artículo científico publicado en 2016

Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma

artículo científico publicado en 2013

Subgroup-specific structural variation across 1,000 medulloblastoma genomes

artículo científico publicado en 2012

Survival and functional outcome of children with hypothalamic/chiasmatic tumors.

artículo científico publicado en 2003

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

artículo científico publicado en 2013

Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children

artículo científico publicado en 2006

The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas

artículo científico publicado en 2017

Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis

artículo científico publicado en 2016

Training subspecialty nurses in developing countries: methods, outcome, and cost

artículo científico publicado en 2003

Tumor-associated macrophages in SHH subgroup of medulloblastomas

artículo científico publicado en 2014

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.

artículo científico publicado en 2015

WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma

artículo científico publicado en 2014

White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.

artículo científico publicado en 2004

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda